Notice of Draft NIJ Law Enforcement Duty Holster Selection and Application Guide, 69458-69459 [2010-28431]
Download as PDF
<![CDATA[
69458
Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices
Secs. 1, 2, and 3;
Secs. 10 to 15, inclusive;
Secs. 22 to 27, inclusive.
Containing approximately 9,210 acres.
T. 38 S., R. 53 W.,
Secs. 1, 12, 13, and 24.
Containing approximately 2,560 acres.
T. 39 S., R. 53 W.,
Secs. 34, 35, and 36.
Containing approximately 1,920 acres.
T. 40 S., R. 53 W.,
Secs. 1 to 19, inclusive;
Secs. 21 to 28, inclusive;
Sec. 36.
Containing approximately 17,896 acres.
T. 41 S., R. 53 W.,
Secs. 1, 4, and 9;
Secs. 11, 12, and 16.
Containing approximately 3,840 acres.
T. 40 S., R. 54 W.,
Secs. 7 to 34, inclusive.
Containing approximately 17,901 acres.
Aggregating approximately 146,693 acres.
Notice of the decision will also be
published four times in the Kodiak
Daily Mirror.
Eileen Ford,
Land Transfer Resolution Specialist, Land
Transfer Adjudication II Branch.
[FR Doc. 2010–28433 Filed 11–10–10; 8:45 am]
BILLING CODE 4310–JA–P
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[CACA–048880, LLCAD060000,
L51010000.FX0000, LVRWB09B2520]
Notice of Availability of the Record of
Decision for the Genesis Solar Energy
Project and Amendment to the
California Desert Conservation Area
Resource Management Plan, Riverside
County, CA
AGENCY:
Bureau of Land Management,
Interior.
ACTION: Notice of availability.
The Bureau of Land
Management (BLM) announces the
availability of the Record of Decision
(ROD)/Approved Amendment to the
California Desert Conservation Area
(CDCA) Plan, the applicable Resource
Management Plan (RMP) for the project
site and the surrounding areas, located
in the California Desert District. The
Secretary of the Interior approved the
ROD on November 4, 2010, which
constitutes the final decision of the
Department.
ADDRESSES: Copies of the ROD/
Approved Amendment to the CDCA
Plan are available upon request from the
Field Manager, Palm Springs-South
Coast Field Office, Bureau of Land
mstockstill on DSKH9S0YB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:23 Nov 10, 2010
Jkt 223001
Management, 1201 Bird Center Drive,
Palm Springs, California 92262 or via
the Internet at the following Web site:
https://www.blm.gov/ca/st/en/fo/
palmsprings.html.
FOR FURTHER INFORMATION CONTACT:
Allison Shaffer, BLM Project Manager;
telephone: (760) 833–7100; mailing
address: 1201 Bird Center Drive, Palm
Springs, California 92262; or e-mail:
CAPSSolarNextEraFPL@blm.gov.
SUPPLEMENTARY INFORMATION: Genesis
Solar, LLC, a wholly owned subsidiary
of NextEra Energy Resources, filed rightof-way (ROW) application CACA–
048880 for the proposed Genesis Solar
Energy Project (GSEP). The GSEP is a
concentrated solar electrical generating
facility using parabolic trough
technology and facilities. The GSEP site
is proposed on approximately 1,950
acres of BLM-managed lands in
Riverside County, California,
approximately 27 miles east of the
unincorporated community of Desert
Center and 25 miles west of the
Arizona-California border city of Blythe.
The GSEP consists of 2 independent
solar electric generating facilities with a
net electrical output of 125 megawatts
(MW) each, resulting in a total net
electrical output of 250 MW. In addition
to the site, the project includes a
distribution line, an electrical
transmission line, fiber optic lines, a
natural gas pipeline, and an access road.
A double circuit 230-kilovolt (kV)
transmission line will be constructed to
connect to the Southern California
Edison Colorado River substation via
the existing Blythe Energy Project
Transmission Line between the Julian
Hinds and Buck substations. The linear
facilities will encumber approximately
90 acres offsite.
The project site is in the California
Desert District within the planning
boundary of the CDCA Plan, which is
the applicable RMP for the project site
and the surrounding areas. The CDCA
Plan, while recognizing the potential
compatibility of solar generation
facilities on public lands, requires that
all sites associated with power
generation or transmission not already
identified in that Plan be considered
through the BLM’s land use plan
amendment process. As a result, prior to
approval of a ROW grant for the GSEP,
the BLM must amend the CDCA Plan to
allow the solar generating project on
that site. The approved Amendment to
the CDCA Plan specifically revises the
CDCA Plan to allow for the
development of the GSEP and ancillary
facilities on land managed by the BLM.
The BLM preferred alternative would
result in the building of 2 adjacent and
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
independent power block units, capable
of generating approximately 250 MW of
electricity, and the use of dry cooling
technology, as well as all associated
ancillary facilities. This 250 MW
alternative was evaluated in the Final
Environmental Impact Statement (EIS).
The Notice of Availability of the Final
EIS for the GSEP and the proposed
CDCA Plan amendment was published
in the Federal Register on August 27,
2010 (75 FR 52736).
Publication of the Notice of
Availability for the Final EIS initiated a
30-day protest period for the proposed
amendment to the CDCA Plan and a 30day comment period on the Final EIS.
At the close of the 30-day period on
September 27, 2010, 3 timely and
complete written protests were received
and resolved. Their resolution is
summarized in the Director’s Protest
Summary Report attached to the ROD.
The proposed amendment to the CDCA
Plan was not modified as a result of the
protest resolution. In addition, the BLM
received 10 comment letters on the
Final EIS. The BLM’s responses to these
comments are provided in Appendix 1
of the ROD. Simultaneously with the
protest period, the Governor of
California conducted a 30-day
consistency review of the proposed
CDCA Plan amendment to identify any
inconsistencies with the state or local
plan, policies, or programs. The
California Governor’s office did not
identify inconsistencies between the
proposed amendment to the CDCA Plan
and state or local plan, policies, or
programs.
Because this decision is approved by
the Secretary of the Interior, it is not
subject to administrative appeal (43 CFR
4.410(a)(3)).
Authority: 40 CFR 1506.6.
Robert V. Abbey,
Director, Bureau of Land Management.
[FR Doc. 2010–28434 Filed 11–10–10; 8:45 am]
BILLING CODE 4310–40–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OJP (NIJ) Docket No. 1526]
Notice of Draft NIJ Law Enforcement
Duty Holster Selection and Application
Guide
National Institute of Justice.
Notice of Draft NIJ Law
Enforcement Duty Holster Selection and
Application Guide.
AGENCY:
ACTION:
In an effort to obtain
comments from interested parties, the
SUMMARY:
E:\FR\FM\12NON1.SGM
12NON1
69459
Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices
U.S. Department of Justice, Office of
Justice Programs, National Institute of
Justice (NIJ) will make available to the
general public the draft ‘‘NIJ Law
Enforcement Duty Holster Selection and
Application Guide.’’ The opportunity to
provide comments on this document is
open to industry technical
representatives, law enforcement
agencies and organizations, research,
development and scientific
communities, and all other stakeholders
and interested parties. Those
individuals wishing to obtain and
provide comments on the draft
document under consideration are
directed to the following Web site:
https://www.justnet.org.
DATES: Comments must be received on
or before December 13, 2010.
FOR FURTHER INFORMATION CONTACT:
Vanessa Castellanos, by telephone at
202–514–5272 [Note: This is not a tollfree telephone number], or by e-mail at
vanessa.castellanos@usdoj.gov.
John H. Laub,
Director, National Institute of Justice.
[FR Doc. 2010–28431 Filed 11–10–10; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on August
26, 2010, Formulation Technologies
LLC., 11400 Burnet Road, Suite 4010,
Austin, Texas 78758, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Fentanyl (9801), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance for analytical
characterization, secondary packaging,
and for distribution to clinical trial sites.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration,
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections
being sent via regular mail should be
addressed, in quintuplicate, to the Drug
Enforcement Administration, Office of
Diversion Control, Federal Register
Representative (ODL), 8701 Morrissette
Drive, Springfield, Virginia 22152; and
must be filed no later than December 13,
2010.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–28527 Filed 11–10–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to Title 21 Code of Federal
Regulations 1301.34 (a), this is notice
that on June 16, 2010, Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402, made
application by renewal to the Drug
Enforcement Administration (DEA) for
registration as an importer of the basic
classes of controlled substances listed in
schedule I and II:
mstockstill on DSKH9S0YB1PROD with NOTICES
Drug
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
N–Ethylamphetamine (1475) .......................................................................................................................................................................
N,N–Dimethylamphetamine (1480) .............................................................................................................................................................
Fenethylline (1503) ......................................................................................................................................................................................
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
Ibogaine (7260) ...........................................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ...............................................................................................................................
Marihuana (7360) ........................................................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Mescaline (7381) .........................................................................................................................................................................................
3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
Alpha-methyltryptamine (7432) ...................................................................................................................................................................
Diethyltryptamine (7434) .............................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
Psilocyn (7438) ............................................................................................................................................................................................
VerDate Mar<15>2010
17:23 Nov 10, 2010
Jkt 223001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\12NON1.SGM
12NON1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 75, Number 218 (Friday, November 12, 2010)]
[Notices]
[Pages 69458-69459]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28431]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OJP (NIJ) Docket No. 1526]
Notice of Draft NIJ Law Enforcement Duty Holster Selection and
Application Guide
AGENCY: National Institute of Justice.
ACTION: Notice of Draft NIJ Law Enforcement Duty Holster Selection and
Application Guide.
-----------------------------------------------------------------------
SUMMARY: In an effort to obtain comments from interested parties, the
[[Page 69459]]
U.S. Department of Justice, Office of Justice Programs, National
Institute of Justice (NIJ) will make available to the general public
the draft ``NIJ Law Enforcement Duty Holster Selection and Application
Guide.'' The opportunity to provide comments on this document is open
to industry technical representatives, law enforcement agencies and
organizations, research, development and scientific communities, and
all other stakeholders and interested parties. Those individuals
wishing to obtain and provide comments on the draft document under
consideration are directed to the following Web site: https://www.justnet.org.
DATES: Comments must be received on or before December 13, 2010.
FOR FURTHER INFORMATION CONTACT: Vanessa Castellanos, by telephone at
202-514-5272 [Note: This is not a toll-free telephone number], or by e-
mail at vanessa.castellanos@usdoj.gov.
John H. Laub,
Director, National Institute of Justice.
[FR Doc. 2010-28431 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-18-P
